Literature DB >> 19164903

Tau aggregation in Alzheimer's disease: what role for phosphorylation?

Guy Lippens1, Alain Sillen, Isabelle Landrieu, Laziza Amniai, Nathalie Sibille, Pascale Barbier, Arnaud Leroy, Xavier Hanoulle, Jean-Michel Wieruszeski.   

Abstract

The crucial role of the neuronal Tau protein in microtubule stabilization and axonal transport suggests that too little or too much Tau might lead to neuronal dysfunction. The presence of a hyper phosphorylated but non aggregated molecule as a toxic species that might sequester normal Tau is discussed. We present recent in vitro results that might allow us to dissect the role of individual phosphorylation sites on its structure and function. We also discuss in this review the role of phosphorylation for the aggregation of the neuronal Tau protein, and compare it to the aggregation induced by external poly anions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19164903      PMCID: PMC2633703          DOI: 10.4161/pri.1.1.4055

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  49 in total

1.  Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.

Authors:  Stefan Barghorn; Peter Davies; Eckhard Mandelkow
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

2.  Template-assisted filament growth by parallel stacking of tau.

Authors:  Martin Margittai; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 3.  Progress towards a molecular-level structural understanding of amyloid fibrils.

Authors:  Robert Tycko
Journal:  Curr Opin Struct Biol       Date:  2004-02       Impact factor: 6.809

4.  Evidence for two distinct binding sites for tau on microtubules.

Authors:  Victoria Makrides; Michelle R Massie; Stuart C Feinstein; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

5.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

Review 6.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

Authors:  Jürgen Götz; Lars M Ittner; Stefan Kins
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

7.  An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice.

Authors:  Sylvie Le Corre; Hans W Klafki; Nikolaus Plesnila; Gabriele Hübinger; Axel Obermeier; Heidi Sahagún; Barbara Monse; Pierfausto Seneci; Jada Lewis; Jason Eriksen; Cynthia Zehr; Mei Yue; Eileen McGowan; Dennis W Dickson; Michael Hutton; Hanno M Roder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

8.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

9.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  20 in total

1.  N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes.

Authors:  Gokulapriya Govindarajalu; Murugan Selvam; Elango Palchamy; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2017-08-04       Impact factor: 3.396

Review 2.  The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration.

Authors:  Ai Yamamoto; Anne Simonsen
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

Review 3.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

4.  Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.

Authors:  Susanne Wegmann; Jonas Schöler; Christian A Bippes; Eckhard Mandelkow; Daniel J Muller
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

5.  Dynein light chain 1 (LC8) association enhances microtubule stability and promotes microtubule bundling.

Authors:  Jayant Asthana; Anuradha Kuchibhatla; Swadhin Chandra Jana; Krishanu Ray; Dulal Panda
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease.

Authors:  Kourosh Shahpasand; Isao Uemura; Taro Saito; Tsunaki Asano; Kenji Hata; Keitaro Shibata; Yoko Toyoshima; Masato Hasegawa; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

7.  How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Authors:  Liang Xu; Jie Zheng; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  ACS Chem Neurosci       Date:  2016-02-24       Impact factor: 4.418

Review 8.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

Review 9.  Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.

Authors:  Rafael I Jaén; Sergio Sánchez-García; María Fernández-Velasco; Lisardo Boscá; Patricia Prieto
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 10.  Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Authors:  Gabriela Dumitrita Stanciu; Razvan Nicolae Rusu; Veronica Bild; Leontina Elena Filipiuc; Bogdan-Ionel Tamba; Daniela Carmen Ababei
Journal:  Biomedicines       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.